Mutations in glial fibrillary acidic protein (GFAP) in astrocytes, as seen in Alexander disease, trigger a significant adverse impact on the efficiency of astrocytic mitochondrial transfer though they fail to alter the number or properties of intracellular mitochondria in astrocytes. Here, GFAP is linked to Alexander disease.